| |
 |
 |
 |
 |
May 9, 2006
Merck
& Co., Inc. to Acquire GlycoFi, Inc.
February 16, 2006
Gerald
Fink, Ph.D. to Join GlycoFi Scientific Advisory
Board
January 23, 2006
GlycoFi
announces the first production of antibodies with
human glycosylation in yeast
December 12, 2005
GlycoFi and Merck & Co., Inc. enter into Broad Strategic Alliance for Research and Development -- Multi-Year Collaboration to Develop Merck Products on GlycoFi Platform
October 10, 2005
GlycoFi Closes Oversubscribed $11 Million Venture Round -- New Board Members
Appointed
October 3, 2005
Eli Lilly & Company and GlycoFi Expand Collaboration With Multi-Product Research and Commercialization Agreement; Strategic Alliance to Include 10 Biotherapeutics
June 2, 2005
GlycoFi Strengthens Management Team; Appoints James Posada, Ph.D., MBA as Senior Vice President of Business and Market Development
April 13, 2005
GlycoFi Signs Research Collaboration with Centocor, Inc. to Evaluate the Expression of Two Proteins
March 21, 2005
2005 GlycoFi is pleased to announce that Richard Fisher, Ph.D. has joined GlycoFi as Vice President of Research and Product Development.
March 16, 2005
GlycoFi, Inc. today announced that Dr. Bryan Lawlis has joined GlycoFi Board of Directors
November 8, 2004
GlycoFi, Inc. has been named by Scientific American magazine as one of the "Scientific American 50"
April 8, 2004
Lilly to Evaluate GlycoFi’s Glycoprotein Production Platform
December 10, 2003
GlycoFi Secures $10M in Series C Financing
|
|
 |
 |
 |
 |
|
|
 |
 |
 |
|
|
|
